Search

Search Constraints

You searched for: Author/Creator Stadler, Walter M.

Search Results

11. Bevacizumab alone or in combination with TRC105 for patients with refractory metastatic renal cell cancer. Issue 23 (22nd August 2017)

12. Biomarker-Based Phase II Study of Sapanisertib (TAK-228): An mTORC1/2 Inhibitor in Patients With Refractory Metastatic Renal Cell Carcinoma. (16th February 2022)

14. Double‐blind, randomized, phase 2 trial of maintenance sunitinib versus placebo after response to chemotherapy in patients with advanced urothelial carcinoma. Issue 5 (18th November 2013)

15. Double‐blind, randomized, phase 2 trial of maintenance sunitinib versus placebo after response to chemotherapy in patients with advanced urothelial carcinoma. Issue 5 (18th November 2013)